93% meeting primary endpoint is not data because we dont know what the primary endpoint was?
Was it being cured?
Was it 50% wound reduction?
Was it 75% wound reduction?
Was it reduction similar to current treatments?
I could go on and on with possible endpoints.
How as an investor can you make an informed decision on the future of this company and the success of RCE 327 based on a a vague statement from a management team that have a history of changing goalposts and hiding failures eg Sepsis.
Secondly, look up the standards for clinical trial reporting on the ASX. Recce's report didn't meet the standards and the lazy and inept ASX never should have approved it.
All I want is a chart or graph and a few numbers to tell me what the hell happened in the trial!!!
P.S don't call me a donut, I'm gluten free.
- Forums
- ASX - By Stock
- RCE
- Ann: Positive Phase II Data from Clinical Trial of R327 Gel
RCE
recce pharmaceuticals ltd
Add to My Watchlist
3.33%
!
31.0¢

Ann: Positive Phase II Data from Clinical Trial of R327 Gel, page-71
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M |
Open | High | Low | Value | Volume |
31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 18938 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13550 | 0.300 |
2 | 34803 | 0.295 |
2 | 50000 | 0.290 |
4 | 131061 | 0.285 |
10 | 251389 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 18938 | 1 |
0.320 | 5000 | 1 |
0.325 | 12600 | 1 |
0.330 | 114230 | 1 |
0.350 | 51319 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online